Showing 1 - 8 results of 8 for search 'Jose Luis Pablos', query time: 0.04s
Refine Results
-
1
Complement as a Therapeutic Target in Systemic Autoimmune Diseases by María Galindo-Izquierdo, José Luis Pablos Alvarez
Published 2021-01-01
Article -
2
-
3
Evaluación del suministro de agua residual tratada por separación, sedimentación, filtración en la salud de cerdos destetados by Abigail Bravo Alcántara, Aldo Mejía Ramos, Gerardo Ramírez Hernández, Marco Antonio Herradora Lozano, José Luis Pablos Hach, Roberto Martínez Gamba
Published 2012-01-01
Article -
4
The CXCL12gamma chemokine displays unprecedented structural and functional properties that make it a paradigm of chemoattractant proteins. by Patricia Rueda, Karl Balabanian, Bernard Lagane, Isabelle Staropoli, Ken Chow, Angelique Levoye, Cedric Laguri, Rabia Sadir, Thierry Delaunay, Elena Izquierdo, Jose Luis Pablos, Elena Lendinez, Antonio Caruz, Diego Franco, Françoise Baleux, Hugues Lortat-Jacob, Fernando Arenzana-Seisdedos
Published 2008-07-01
Article -
5
Inhibitory Role of Growth Hormone in the Induction and Progression Phases of Collagen-Induced Arthritis by Ricardo Villares, Gabriel Criado, Yasmina Juarranz, Mercedes Lopez-Santalla, Mercedes Lopez-Santalla, Eva M. García-Cuesta, José M. Rodríguez-Frade, Javier Leceta, Pilar Lucas, José Luis Pablos, Carlos Martínez-A, Marina I. Garin, Marina I. Garin, Rosa P. Gomariz, Mario Mellado
Published 2018-05-01
Article -
6
Expert Consensus: Main Risk Factors for Poor Prognosis in COVID-19 and the Implications for Targeted Measures against SARS-CoV-2 by Francisco Javier Candel, Pablo Barreiro, Miguel Salavert, Alfonso Cabello, Mario Fernández-Ruiz, Pedro Pérez-Segura, Jesús San Román, Juan Berenguer, Raúl Córdoba, Rafael Delgado, Pedro Pablo España, Ignacio Alberto Gómez-Centurión, Juan María González del Castillo, Sarah Béatrice Heili, Francisco Javier Martínez-Peromingo, Rosario Menéndez, Santiago Moreno, José Luís Pablos, Juan Pasquau, José Luis Piñana, on behalf of the MODUS Investigators (Adenda)
Published 2023-06-01
Article -
7
Effectiveness of anakinra for tocilizumab-refractory severe COVID-19: A single-centre retrospective comparative study by Cristina de la Calle, Francisco López-Medrano, José Luis Pablos, Jaime Lora-Tamayo, Guillermo Maestro-de la Calle, Marcos Sánchez-Fernández, Mario Fernández-Ruiz, María Asunción Pérez-Jacoiste Asín, José Manuel Caro-Teller, Rocío García-García, Mercedes Catalán, Joaquín Martínez-López, Ángel Sevillano, Julia Origüen, Mar Ripoll, Rafael San Juan, Antonio Lalueza, Borja de Miguel, Octavio Carretero, Fernando Aguilar, Carlos Gómez, Estela Paz-Artal, Héctor Bueno, Carlos Lumbreras, José María Aguado
Published 2021-04-01
Article -
8
Analysis of the factors predicting clinical response to tocilizumab therapy in patients with severe COVID-19 by Rafael San-Juan, Mario Fernández-Ruiz, Francisco López-Medrano, Octavio Carretero, Antonio Lalueza, Guillermo Maestro de la Calle, María Asunción Pérez-Jacoiste Asín, Héctor Bueno, José Manuel Caro-Teller, Mercedes Catalán, Cristina de la Calle, Rocío García-García, Carlos Gómez, Rocío Laguna-Goya, Manuel Lizasoáin, Joaquín Martínez-López, Julia Origüen, Ángel Sevillano, Eduardo Gutiérrez, Borja de Miguel, Fernando Aguilar, Patricia Parra, Mar Ripoll, Tamara Ruiz-Merlo, Hernando Trujillo, José Luis Pablos, Estela Paz-Artal, Carlos Lumbreras, José María Aguado
Published 2022-04-01
Article